Success Metrics

Clinical Success Rate

91.7%

Based on 11 completed trials

Completion Rate

92%(11/12)

Active Trials

0(0%)

Results Posted

18%(2 trials)

Terminated

1(8%)

Phase Distribution

Ph phase_2

42%

Ph phase_4

25%

Ph phase_1

Ph phase_3

17%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution11 total trials

Phase 1Safety & dosage

1(9.1%)

Phase 2Efficacy & side effects

5(45.5%)

Phase 3Large-scale testing

2(18.2%)

Phase 4Post-market surveillance

3(27.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

91.7%

11 of 12 finished

Non-Completion Rate

8.3%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(11)

Terminated(1)

Detailed Status

Completed11

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

91.7%

Most Advanced

Phase 4

Trials by Phase

Phase 11 (9.1%)

Phase 25 (45.5%)

Phase 32 (18.2%)

Phase 43 (27.3%)

Trials by Status

terminated18%

completed1192%

Recent Activity

0 active trials

Showing 5 of 12

completed

A Retrospective And Multicenter Survey To Investigate The Dosage, Efficacy And Safety Of Sertraline In Posttraumatic Stress Disorder Patients

NCT01607593

completedphase_4

Clinical Trials (12)

Showing 12 of 12 trials

NCT01607593

A Retrospective And Multicenter Survey To Investigate The Dosage, Efficacy And Safety Of Sertraline In Posttraumatic Stress Disorder Patients

Completed

NCT00009191Phase 4

The Depression in Alzheimer's Disease Study (DIADS)

Completed

NCT00086138Phase 2

Depression in Alzheimer's Disease-2

Completed

NCT00229476Phase 4

Study of Medication and Placebo Response in Major Depression

Completed

NCT00004554Phase 4

Sertraline for Alcohol Dependence and Depression

Completed

NCT00179257Phase 3

The Effectiveness of Sertraline in Patients Who Have Had Inadequate Response to Escitalopram

Completed

NCT00331305Phase 3

Exercise Training Versus Drug Therapy for Treating Depression in Older Adults

Completed

NCT00208117Phase 1

A Trial of Inflammatory Markers, Depressive Symptoms, and Heart Disease

Terminated

NCT00001483Phase 2

Acute Effectiveness of Additional Drugs to the Standard Treatment of Depression

Completed

NCT00000446Phase 2

Drug Treatment for Alcoholics With Post-Traumatic Stress Disorder

Completed

NCT00000440Phase 2

Sertraline and Naltrexone for Alcohol Dependence

Completed

NCT00000458Phase 2

Sertraline and Cognitive Therapy in Depressed Alcoholics

Completed

All 12 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 12